Lixte Biotechnology

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
EBITDA
-1,574
-984
-1,009
-4
EBIT
-609
-983
-1,009
-971
Net Income
-617
-986
-1,010
-971
Net Change In Cash
0
0
0
0
Free Cash Flow
-598
-957
-819
-789
Cash
1,038
1,637
2,595
3,414
Basic Shares
2,249
2,249
2,249
2,249

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
EBITDA
-3,572
3
-1
-7
EBIT
-5,087
-6,312
-6,728
Net Income
-3,585
-5,087
-6,304
-6,735
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,164
-4,293
-4,611
-4,142
Cash
1,038
4,203
5,353
4,823
Basic Shares
2,249
1,915
158
1,347